We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$10.4B
AUM Growth
+$576M
Cap. Flow
+$80.3M
Cap. Flow %
0.78%
Top 10 Hldgs %
38.6%
Holding
1,407
New
91
Increased
858
Reduced
433
Closed
18
Avg Time Held
12.2 quarters
Top 10 Avg Time Held
13 quarters
Top 20 Avg Time Held
11.3 quarters

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$12.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.5M
3
META icon
Meta Platforms (Facebook)
META
+$8.69M
4
V icon
Visa
V
+$8.21M
5
AMZN icon
Amazon
AMZN
+$6.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$7.31M
2
VRSK icon
Verisk Analytics
VRSK
+$5.19M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.16M
4
IT icon
Gartner
IT
+$4.49M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$3.73M

Sector Composition

Rank Sector Weight
1 Technology 35.83%
2 Consumer Discretionary 11.41%
3 Financials 11.04%
4 Healthcare 10.64%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CALM icon
1151
Cal-Maine
CALM
$2.93B
$252K ﹤0.01%
3,366
-701
-17% -$48.5K
2024 Q2
1 quarter
IIPR icon
1152
Innovative Industrial Properties
IIPR
$1.42B
$249K ﹤0.01%
+1,847
New +$225K
2024 Q3
0 quarters
RXO icon
1153
RXO
RXO
$4.72B
$249K ﹤0.01%
+8,877
New +$251K
2024 Q3
0 quarters
FTDR icon
1154
Frontdoor
FTDR
$5.36B
$246K ﹤0.01%
+5,129
New +$222K
2024 Q3
0 quarters
MDGL icon
1155
Madrigal Pharmaceuticals
MDGL
$10.4B
$245K ﹤0.01%
1,155
+38
+3% +$9.72K
2023 Q4
3 quarters
BHVN icon
1156
Biohaven
BHVN
$1.72B
$244K ﹤0.01%
+4,885
New +$190K
2024 Q3
0 quarters
PLXS icon
1157
Plexus
PLXS
$6.87B
$244K ﹤0.01%
+1,785
New +$217K
2024 Q3
0 quarters
BROS icon
1158
Dutch Bros
BROS
$5.24B
$244K ﹤0.01%
7,604
+631
+9% +$22.2K
2024 Q2
1 quarter
FUN icon
1159
Cedar Fair
FUN
$1.04B
$241K ﹤0.01%
+5,973
New +$273K
2024 Q3
0 quarters
WD icon
1160
Walker & Dunlop
WD
$1.1B
$239K ﹤0.01%
+2,107
New +$221K
2024 Q3
0 quarters
JWN icon
1161
DELISTED
Nordstrom
JWN
$238K ﹤0.01%
10,598
-112
-1% -$2.49K
2020 Q3
16 quarters
ACLX icon
1162
DELISTED
Arcellx
ACLX
$238K ﹤0.01%
+2,844
New +$189K
2024 Q3
0 quarters
DNLI icon
1163
Denali Therapeutics
DNLI
$2.94B
$237K ﹤0.01%
+8,135
New +$202K
2024 Q3
0 quarters
LRN icon
1164
Stride
LRN
$3.45B
$237K ﹤0.01%
+2,775
New +$214K
2024 Q3
0 quarters
NWL icon
1165
Newell Brands
NWL
$2.38B
$236K ﹤0.01%
30,789
+15,526
+102% +$111K
2020 Q2
17 quarters
AXS icon
1166
AXIS Capital
AXS
$7.12B
$236K ﹤0.01%
+2,968
New +$222K
2024 Q3
0 quarters
CRC icon
1167
California Resources
CRC
$4.82B
$236K ﹤0.01%
4,503
+77
+2% +$3.89K
2023 Q3
4 quarters
AZN icon
1168
AstraZeneca
AZN
$242B
$236K ﹤0.01%
+1,516
New +$245K
2024 Q3
0 quarters
RCM icon
1169
DELISTED
R1 RCM Inc. Common Stock
RCM
$236K ﹤0.01%
16,627
-2,950
-15% -$40.1K
2021 Q2
13 quarters
BBIO icon
1170
BridgeBio Pharma
BBIO
$12.4B
$235K ﹤0.01%
9,245
+374
+4% +$9.82K
2023 Q4
3 quarters
TXG icon
1171
10x Genomics
TXG
$9.35B
$235K ﹤0.01%
10,413
+200
+2% +$4.13K
2020 Q2
17 quarters
PBH icon
1172
Prestige Consumer Healthcare
PBH
$2.3B
$234K ﹤0.01%
3,242
+100
+3% +$7.08K
2024 Q1
2 quarters
CVCO icon
1173
Cavco Industries
CVCO
$4.06B
$233K ﹤0.01%
+545
New +$215K
2024 Q3
0 quarters
FORM icon
1174
FormFactor
FORM
$10B
$233K ﹤0.01%
5,071
+146
+3% +$7.29K
2024 Q1
2 quarters
IDCC icon
1175
InterDigital
IDCC
$8.59B
$233K ﹤0.01%
+1,645
New +$216K
2024 Q3
0 quarters
45 46
47
48 49

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Xponance's Q3 2024 Portfolio in Review

As of Q3 2024, Xponance held 1,407 positions worth $10.4B, up 5.9% from $9.78B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance's Q3 2024 filing shows 91 new, 858 increased, 433 reduced and 18 closed positions. Its largest new stake was Smurfit Westrock: 106,066 shares worth $5.24M. The largest sale was Eli Lilly, an estimated $7.31M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Xponance's largest Q3 2024 buy was Smurfit Westrock: 106,066 shares worth $5.24M.
  • Xponance added most to Broadcom in Q3 2024, an estimated $12.5M increase.
  • Xponance's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $7.31M.
  • Xponance fully exited Invesco S&P 500 Concentrated QVM ETF in Q3 2024, selling an estimated $3.61M.
  • Xponance's ten largest holdings make up 39% of its $10.4B portfolio in Q3 2024.
  • Xponance opened 91 new positions and closed 18 in Q3 2024.
  • Xponance's portfolio value rose 5.9% quarter-over-quarter to $10.4B.

Based on Xponance's 13F filing for Q3 2024, filed 12 Nov 2024.